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Abstract
Membrane-bound transcription factors (MTFs) are transcription factors (TFs) that are anchored in membranes in a
dormant state. Activated by external or internal stimuli, MTFs are released from parent membranes and are transported
to the nucleus. Existing research indicates that some plasma membrane (PM)-bound proteins and some endoplasmic
reticulum (ER) membrane-bound proteins have the ability to enter the nucleus. Upon specific signal recognition cues,
some PM-bound TFs undergo proteolytic cleavage to liberate the intracellular fragments that enter the nucleus to
control gene transcription. However, lipid-anchored PM-bound proteins enter the nucleus in their full length for
depalmitoylation. In addition, some PM-bound TFs exist as full-length proteins in cell nucleus via trafficking to the Golgi
and the ER, where membrane-releasing mechanisms rely on endocytosis. In contrast, the ER membrane-bound TFs
relocate to the nucleus directly or by trafficking to the Golgi. In both of these pathways, only the fragments of the ER
membrane-bound TFs transit to the nucleus. Several different nuclear trafficking modes of MTFs are summarized
in this review, providing an effective supplement to the mechanisms of signal transduction and gene regulation.
Moreover, targeting intracellular movement pathways of disease-associated MTFs may significantly improve the
survival of patients.
Background
Gene expression is controlled by specific interactions
between transcription factors, regulatory proteins, and
cis-elements in the gene regulatory regions [1]. Existing
research shows that transcription factors are not only
proteins but numerous non-coding RNAs act as regula-
tors of transcription [2]. Many long non-coding RNAs
have been found to play important roles in the regula-
tion of gene expression [3]. Most transcription factors
are located in the cytoplasm. After receiving a signal
from the cell membrane signal transduction, transcrip-
tion factors are activated and then translocated from the
cytoplasm into the nucleus where they interact with the
corresponding DNA frame (cis-acting elements). A tran-
scription factor usually has one or more DNA-binding
domains, and therefore can regulate the expression of
multiple genes. Conversely, one gene can be regulated
by many transcription factors.
Some membrane proteins play a transcription regula-
tory role after being translocated into the nucleus.
Membrane-bound transcription factors (MTFs) have
been observed in many types of organisms, such as
plants, animals and microorganisms [4–6]. According to
the activation routes of general transcription factors,
these molecules are regulated at many points throughout
signal transduction in an exquisite process. As a result,
membrane-bound transcription factors can respond rap-
idly to stresses from either extracellular or intracellular
stimuli [7]. Full-length MTFs are synthesized in the
cytoplasm and are rapidly transported to the cellular
membrane [8]. Once they are anchored in the cell mem-
brane, MTFs remain in a dormant state [7, 9]. Cellular
stimuli can activate transcription factor precursors and
induce their nuclear translocation. Nuclear translocation
signals that have been established include ligand-
receptor binding response signals as well as many types
of stress, such as nerve injury stress, temperature stress,
endoplasmic reticulum (ER) stress, and oxidative stress,
among others [10–14]. In this review, we mainly focus
on how MTFs move within the cell and whether they
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turn to other organelle membranes during their nuclear
translocation. We separate MTFs into two groups:
plasma membrane-bound (PM) transcription factors and
ER membrane-bound transcription factors. PM proteins
are translocated into the nucleus directly or by Golgi to
ER retrograde trafficking, either in their full-length or in
their cytosolic fragmented form. ER membrane-bound
proteins are translocated into the nucleus directly or by
trafficking first to the Golgi from the ER, but both
routes give rise to the fragments of the proteins finally
entering the nucleus.
The nuclear transportation routes of plasma
membrane-bound proteins
Plasma membrane-bound proteins are translocated into
the nucleus directly
RIP-dependent release from the plasma membrane
Some transmembrane proteins are cleaved within the
membrane to release cytosolic segments which are then
transported to the nucleus to regulate gene transcrip-
tion. This mechanism is called regulated intramembrane
proteolysis (RIP) [15]. Some proteins are located in the
plasma membrane and are processed by RIP to release
from the plasma membrane. They consist of extracellu-
lar, transmembrane and intracellular subunits. As cell
membrane proteins, they are activated by external
signals. After proteolysis, their active regions are directly
translocated into the nucleus (Fig. 1a1-a2). Here, we
provide three examples including Notch, Leukocyte-
common antigen-related receptor tyrosine phosphatase
(LAR), and amyloid precursor protein (APP).
Notch precursor is first cleaved by a furin-like conver-
tase to generate two subunits within the Golgi apparatus.
It is then anchored in the plasma membrane. With the
interactions between a transmembrane ligand of the
Delta-Serrate Lag family and EGF-like repeats of the
extracellular domain of Notch receptors, conformational
changes in the receptor expose critical sides for next two
steps of cleavage. The second cleavage by a metallopro-
teinase, a disintegrin and metallop 17 (ADAM17), occurs
at the extracellular region near the membrane. The extra-
celluar N-terminal cleavage products are endocytosed by
the signal-sending cell. The third cleavage, mediated by γ-
secretase, acts on the intracellular region near the mem-
brane and results in liberation and translocation of the
active segment of Notch (NICD, Notch intracellular do-
main) to the nucleus. In the nucleus, it activates Notch
target gene transcription by forming a ternary complex
with C-promoter binding factor 1 and the Mastermind-
like family of proteins (MAML 1/2/3) [16]. Notch signal-
ling plays a critical role in diverse cellular processes
including proliferation, differentiation, and apoptosis. It
Fig. 1 The nuclear transportation routes of plasma membrane-bound proteins. (a1-a2) Some PM proteins are cleaved by regulated intramem-
brane proteolysis. The fragments facing to cytosol are released and relocated to the nucleus. (b1-b2) Some of them attach to the plasma
membrane by palmitoylation. They release from the plasma membrane by depalmitoylation and then enter the nucleus upon signal induc-
tion. (c1-c5) Some proteins release from the membrane by endocytosis and then go to the Golgi. Through Golgi to ER retrograde trafficking, they are
finally translocated into the nucleus
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can also act as an oncogene or tumour suppressor in dif-
ferent tumour subtypes [17–19]. Furthermore, recent re-
search reveals that multipotency of Drosophila intestinal
stem cells is regulated by bidirectional Notch signalling.
On the one hand, low Notch signalling from a basal enter-
oendocrine cell to an apical intestinal stem cell blocks
enteroendocrine cell differentiation and maintains intes-
tinal stem cell identity. On the other hand, strong Notch
signalling from a basal intestinal stem cell to an apical
enteroblast promotes enterocyte differentiation [20].
LAR regulates neurite outgrowth and synaptic devel-
opment by binding to its ligands. The full length LAR is
first cleaved by furin to expose its two subunits, which
remain noncovalently associated on the plasma mem-
brane. An activating signal results in the α-secretase-
mediated second cleavage and release of the extracellular
subunit. The third cleavage of the membrane-bound
subunit by γ-secretase generates the LAR intracellular
domain (LICD). Some LICDs are translocated into the
nucleus by interaction with β-catenin and regulate the
β-catenin-dependent gene expression [21].
Amyloid precursor protein (APP) undergoes a similar
process to that of the Notch and LAR activation path-
ways, as was presented above. APP is cleaved to generate
several fragments including APP intracellular domain
(AICD) and the amyloid β peptides. Nuclear AICD is
cleaved by β-secretase followed by γ-secretase, while the
AICD formed by α-secretase and γ-secretase mainly pro-
ceeds to degradation [22]. AICD induces cell death by
interacting with Forkhead box (FOX) O in the nucleus
upon oxidative stress, and promotes the FoxO-induced
pro-apoptotic gene Bim expression as a transcription co-
activator [23]. The AICD negatively regulates transcrip-
tion of Wasf1 and decreases Wasf1 mRNA and protein
levels in Neuro 2a cells [24].
Depalmitoylation-dependent release from the plasma
membrane
There are some transcription factors such as NFAT5a
and MfNACsa, which are attached to the plasma mem-
brane by lipid anchors. Upon stimulatory signal, these
TFs are depalmitoylated, which releases them from the
plasma membrane, and they can then be translocated
into the nucleus (Fig. 1b1-b2).
MfNACsa, which belongs to the plant-specific NAC
(NAM, ATAF1/2 and CUC2) transcription factors, is a
regulator of plant tolerance to drought stress. Under un-
stressed conditions, MfNACsa is attached to the plasma
membrane through palmitoylation, a lipid modification.
Upon drought stress, MfNACsa relocates to the nucleus
through depalmitoylation mediated by the thioesterase
MtAPT1. The nuclear MfNACsa binds the glyoxalase I
promoter, resulting in drought tolerance by suppressing
glutathione levels [25].
The NFAT5α (nuclear factor of activated T-cells 5, iso-
form α) transcription factor of Homo sapiens is attached
to the plasma membrane via both myristoylation and
palmitoylation in the resting state. Under osmotic stress
conditions, the plasma membrane-bound NFAT5α is
transclocated into the nucleus, mediated by reversible
palmitoylation but not by proteolytic processing of the
lipid-anchored N-terminal region [26].
Plasma membrane-bound proteins are translocated into
the nucleus by Golgi-ER retrograde trafficking
PM-proteins can be released from the plasma mem-
brane by an endocytosis-dependent process. They are
internalized by endocytic vesicles (Fig. 1c1) and then
are relocated to the Golgi apparatus (Fig. 1c2). They
exit from the Golgi through budding (Fig. 1c3),
which is mediated by COPI-coated vesicles and are
then transported to the endoplasmic reticulum (ER)
(Fig. 1c4). Finally, they are transported to the nucleus
in full length (Fig. 1c5).
A typical example undergoing this mode of trans-
port is epidermal growth factor receptor (EGFR).
EGFR internalization is dependent on binding to its
ligand. Different ligands acting on EGFR result in dif-
ferent effects. There are many kinds of EGFR ligands,
including TGF-α, β-Cellulin, EGF, HB-EGF, epiregulin,
and amphiregulin. EGFR is translocated into the nu-
cleus after stimulation with TGF-α, β-Cellulin, EGF
and HB-EGF. These ligands are related to increasing
phosphorylation of EGFR tyrosine residues, and in-
duce cell migration. In contrast, both epiregulin and
amphiregulin ligands do not result in EGFR nuclear
translocation [27].
The endocytosis of EGFR is divided into two categor-
ies: clathrin-mediated endocytosis (CME) and noncla-
thrin endocytosis (NCE) [28–30]. At low EGF
concentrations (1 ng/ml), EGFRs are primarily inter-
nalized by CME [31]. At high EGF concentrations
(20 to 100 ng/ml), EGFR is internalized through
CME and NCE. EGFR-NCE is cholesterol and
dynamin-dependent, but caveolin-independent, and
requires EGFR ubiquitination and proteins harbour-
ing ubiquitin-binding domains [31, 32]. NCE-
mediated plasma membrane (PM) invagination pro-
cesses occurs at ER-PM contact sites with the help of
reticulon 3. Local Ca2+ release occurs at ER contact
sites when tubular invaginations (TI) are formed and
is required for the fission of NCE-TI. This Ca2+
release process also requires CD147, which is a cargo
internalized by NCE [33]. Internalized EGFR is sorted
by early endosomes (EE). Some parts of EGFR
located in the EE are translocated into the late
endosome and are degraded by relocation to the
lysosome. Some parts of EGFR located in the EE
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recycle to the cell surface [34]. Other parts are first
translocated into the Golgi membrane and then are
transferred to the ER membrane, mediated by COPI-
coated trafficking vesicles, and they finally enter the
nucleus through the nuclear pore complex [35–37].
EGFR functions as a transcription co-activator with
an intrinsic transactivation activity at the C-terminal
acidic region. It promotes iNOS gene expression by
interaction with transcription factor STAT3 and RNA
helicase A. EGFR also promotes cyclin D1 gene ex-
pression by interaction with RNA helicase A and
promotes the expression of COX-2, Aurora-A and c-
Myc genes by interaction with STAT3/5. EGFR in-
duces B-Myb gene expression by interaction with
E2F1 [36]. Nuclear EGFR is known to play an im-
portant role in tumours. Nuclear transport of EGFR
is mediated by vesicular trafficking protein Vps34,
and EGFR is recruited to the Arf promoter to repress
the transcription of Arf tumour suppressor [38].
Moreover, in renal cell carcinoma, recent evidence
indicates that the membranous expression of EGFR
has a correlation with poorly differentiated and high
nuclear grade tumours, while nuclear EGFR expres-
sion is high in well differentiated and low nuclear
grade tumours [39].
The nuclear transportation routes of ER
membrane-bound proteins
ER membrane-bound proteins are translocated into the
nucleus directly
RUP-dependent process
Some ER membrane proteins are translocated into the
nucleus directly by regulated ubiquitin/proteasome-
dependent processing (RUP). Proteins are ubiquitinated
by ubiquitinating enzymes (Fig. 2A, a1), which trigger
the ubiquitin/proteasome-dependent degradation pro-
cess (Fig. 2A, a2). The portions within the ER lumen
and transmembrane regions are degraded, leaving the
free cytosic segments to enter the nucleus (Fig. 2A, a3).
A yeast transcription factor, suppressor of Ty 23
(SPT23), is regarded as a ER/nuclear membrane-
localized dormant precursor and is activated by ubiqui-
tin/proteasome-dependent processing. After ubiquitina-
tion of the substrate catalysed by ubiquitin-activating
enzyme, ubiquitin-conjugating enzyme, and the RSP5
ubiquitin ligase, the proteasome releases the N-terminal
transcription factor domain (p90) by an endoproteolytic
reaction. The C-terminal tail is likely degraded by a
process that resembles ER-associated degradation [4].
Another study revealed that SPT23 at the ER dimer-
ized via the Ig-like/plexins/transcription factor (IPT)
Fig. 2 ER membrane-bound proteins are translocated into the nucleus directly. (a) Nuclear translocation by RUP. (a1) Proteins get ubiquitinated
by ubiquitin ligase. (a2) The ubiquitinated precursor is then processed by a proteasome. The portion within the ER lumen and transmembrane
span are degraded by proteasomes. (a3) The active segments enter the nucleus to regulate gene expression. (b) Nuclear translocation by auto-proteolysis.
(b1-b2) ER membrane proteins undergo autocatalytic proteolysis, and then the liberated cytosolic fragments are translocated into the nucleus. (c) Nuclear
translocation by alternative splicing. (c1) Unspliced mRNA transfers to the ER and is spliced by ER enzymes. (c2-c3) Protein fragments translated by spliced
mRNA are transported to the nucleus to regulate gene expression
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domains before RSP5-mediated monoubiquitination.
Processing of SPT23 by the proteasome leads to p90,
which is associated with an uncleaved p120 partner
molecule. This processing might be assisted by
CDC48, ubiquitin fusion degradation 1 (UFD1) and
nuclear pore localization 4 (NPL4). The processed p90
retains its ubiquitin modification, and CDC48UFD1/
NPL4 removes p90 from its p120 partner. Subse-
quently, p90 enters the nucleus to drive OLE1 gene
transcription [40].
Auto-proteolytic-dependent process
Other ER membrane proteins are translocated directly
into the nucleus mediated by the auto-proteolytic-
dependent releasing mechanism. These proteins have a
completely different cleavage mechanism in contrast to
RIP or RUP. They undergo an autocatalytic process and
are not catalysed by extrinsic proteases. After auto-
proteolysis (Fig. 2B, b1), their cytosolic fragments are re-
leased and transported to the nucleus directly (Fig. 2B, b2).
Here, we provide two examples to illustrate this method.
Myelin regulatory factor (MYRF) is a type-II membrane
protein localized on the ER. Trimerization-dependent
auto-proteolysis separates its transmembrane domain-
containing C-terminal region from its N-terminal frag-
ment. The auto-proteolytic cleavage mechanism has been
previously described for the intramolecular chaperone
domains of bacteriophage tail-spike proteins. The active
N-terminal trimer with two nuclear localization signals is
translocated into the nucleus to directly bind the enhancer
regions of oligodendrocyte-specific and myelin genes. This
signalling also drives synaptic rewiring [41–43].
MrfA, a homologous protein of the metazoan MYRF
proteins, is a transcription factor that regulates differen-
tiation of dictyostelium prestalk cells. MrfA is inserted
into the ER by its C-terminus-proximal transmembrane
(TM) domain. In the ER, the auto-proteolysis of MrfA
occurs rapidly and constitutively. The cleavage position
lies in its MRF domain, which has extensive similar se-
quence compared with the C-terminal intramolecular
chaperone domain of bacteriophage tail and spike fibre.
Additionally, the MRF domain of MrfA contains a
serine-lysine dyad that directs its cleavage. The liberated
fragment remains cytosolic in growing cells, while the
liberated fragment is activated and accumulated in
the nucleus in some anterior-like cells and prestalk
cells. Due to the regulated nuclear translocation of
the liberated fragment, MrfA has a role in prestalk
cell differentiation [9].
Alternative splicing-dependent process
Still other ER membrane-bound proteins are translo-
cated into the nucleus directly, mediated by the alterna-
tive splicing-dependent mechanism. With stimuli such
Fig. 3 ER membrane-bound proteins relocate in the nucleus by trafficking to the Golgi. (a1-a2) ER membrane-located proteins are transported to
the Golgi by COPII vesicles. (a3) Within the Golgi apparatus they are cleaved by Golgi-resident proteases. (a4) Finally, soluble cytosolic segments
enter the nucleus to play a transcription regulation role
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as ER stress, unspliced mRNA goes to the ER and is
spliced by an ER enzyme (Fig. 2C, c1). Protein frag-
ments translated by splicing mRNA (Fig. 2C, c2) are
transported to the nucleus to regulate gene expression
(Fig. 2C, c3).
The protein bZIP60 encoded by unspliced mRNA is
predicted to be a type II membrane protein in the ER
with a single transmembrane domain. In maize, the seg-
ment of mRNA encoding bZIP60 is folded into a twin
loop structure. In response to ER stress, the mRNA is
spliced by cleaving a 20b intron by a membrane-
associated dual-functioning protein kinase/ribonuclease
known as inositol-requiring enzyme 1 (IRE1). Splicing
transforms the predicted protein from a membrane-
associated transcription factor to the active bZIP tran-
scription factor, which is then targeted to the nucleus. In
maize seedlings, bZIP60 splicing is initiated by ER stress
agents such as tunicamycin or dithiothreitol or by heat
treatment [44].
X-box-binding protein 1 (XBP1) is also known to be
activated by a splicing-dependent mechanism. XBP1 is
activated by ER membrane enzyme-mediated splicing.
Under ER stress conditions, unspliced XBP1 messenger
RNA precursor (XBP1u mRNA) is spliced on the ER
membrane by IRE1. After translation, active transcrip-
tion factor XBP1s (the spliced form of XBP-1) goes to
the nucleus to alleviate ER stress [45]. After partial hepa-
tectomy, XBP1 enters the nucleus to induce STAT3
transcription. Decreased XBP1 levels promote DNA
damage responses in regenerating hepatocytes [46].
ER membrane-bound proteins are translocated into the
nucleus by trafficking to the Golgi
Some proteins are first located in the ER membrane and
are activated upon ER stress. When activated, these pro-
teins leave the ER and are transferred to the Golgi by
COPII-mediated trafficking vesicles (Fig. 3a1-a2). Within
the Golgi apparatus, they are cleaved by Golgi-resident
proteases (Fig. 3a3). Finally, the soluble cytosolic seg-
ments enter the nucleus to exert a transcription regula-
tion role (Fig. 3a4). Examples are provided to illustrate
this mode, including sterol regulatory element-binding
protein (SREBP), plant bZIP TF family protein bZIP28
and several activating transcription factor (ATF)/cAMP
response element-binding protein (CREB) family pro-
teins, such as activating transcription factor 6 (ATF6),
old astrocyte specifically induced substance (OASIS) and
spinal cord injury and regeneration-related protein #69
(SCIRR69).
For SREBP, recent research demonstrates that EGFR
signalling increases glucose uptake, and then promotes
N-glycosylation of SREBP cleavage-activating protein
(SCAP). Glycosylation promotes the stability of SCAP,
reduces linkage between insulin-induced gene 1 and
SCAP, and makes SCAP/SREBP move from the ER to
the Golgi. Activated N-terminal fragments generated by
protein enzyme cleavage enter the nucleus and promote
tumour growth by regulating the expression of lipogen-
esis genes [47]. Structural analysis on endoplasmic
reticulum membrane–anchored sterol sensors, Insigs,
reveals that they form a V-shaped cavity with their six
transmembrane segments (TMs). TM3 and TM4 are re-
sponsible for Insig-2 binding to SCAP [48].
The plant basic leucine zipper (bZIP) transcription fac-
tor, bZIP28, is a type II membrane protein which has a
single transmembrane domain. Its N-terminal fragment
faces the cytosolic side, and its C-terminal fragment
faces the ER lumen side. bZIP28 interacts with binding
immunoglobulin protein (BiP) in the ER lumen via its
C-terminal domain. The release of BiP from bZIP28 is
responsible for ER-Golgi trafficking of bZIP28 under
stress conditions [49]. It has been extensively recognized
that the activation of bZIP28 is achieved by site-1 and
site-2 protease, which are Golgi-resident proteases. How-
ever, a recent study reveals that bZIP28 cleavage is medi-
ated by site-2 protease, but not by site-1 protease [50].
As to ATF6, dissociation of BiP from ATF6 is also im-
portant for its ER-Golgi translocation. ATF6 is known to
induce the expression of ER stress response genes under
ER stress conditions. However, ATF6 induces the ex-
pression of numerous oxidative stress response genes
after ischaemia/reperfusion [51]. Upon bacterial infection,
ATF6 is also critical for regulating interferon gamma-
induced Dapk1 expression by association with CCAAT/
enhancer-binding protein beta. Without ATF6, interferon
gamma fails to induce autophagy in cells. This result links
ER stress and autophagy [52].
OASIS is a basic leucine zipper (bZIP) transcription fac-
tor which belongs to the CREB/ATF family. During ER
stress, it is notable that OASIS is not induced at the tran-
scriptional level in any other cell types examined but only
in astrocytes of the central nervous system, which exhibit
cell type-specific unfolded protein response signalling [53].
SCIRR69 is located in the cytoplasm of primary neu-
rons under normal conditions, but it is transferred to
the nucleus via shedding from the membrane upon
neuron damage [12]. SCIRR69 regulates BDNF gene ex-
pression [54]. SCIRR69-dependent signalling involves
protein interactions with sideroflexin-1 and transitional
endoplasmic reticulum ATPase [55].
Conclusion
Compared with common transcription factors, MTFs
obviously belong to a special class of transcription fac-
tors. Their movement ability is limited until activated by
stimuli. The release of dormant MTFs provides a means
for rapid responses to external and internal stimuli, and
they are considered to play important roles in signalling
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upon various cues and stresses. As mentioned above,
MTFs play critical roles in environmental stress and cel-
lular ER stress responses. They help plants to cope with
unfavourable growth conditions by regulating gene ex-
pression with their transcriptional activity [56]. Extend-
ing our understanding of the molecular mechanisms
underlying how intracellular movement of MTFs is orga-
nized may provide us with an advantage by enabling
plants to increase their stress tolerance. Moreover, there
are also some MTFs which are involved in the develop-
ment and progression of tumours, such as Notch, EGFR
and SREBP. Examination of the subcellular locations
where they are processed and of their related functional
proteins may provide potential molecular targets for de-
signing novel therapeutic drugs. Nuclear translocation
regulation of MTFs occurs through a series of events.
Targeting the modulation of membrane properties,
spatial structure of membrane proteins and the corre-
sponding processes of proteases could potentially trans-
form nuclear transport routes such as endocytosis or
ER-Golgi trafficking. This may significantly improve the
survival of patients, for example, γ-secretase inhibitors
(GSIs) suppress tumour growth in several preclinical
cancer models by blocking the cleavage of Notch at the
cell membrane, effectively inhibiting the release of the
active NICD subunit [57–59]. Studies have shown that
patients with high nuclear EGFR levels have poor clinical
outcomes in breast cancer [60], which implies that nu-
clear EGFR may benefit tumours by helping to evade cell
surface EGFR-targeted small molecule inhibitors and
therapeutic antibodies. Therefore, inhibition of EGFR
nuclear translocation may increase overall survival of pa-
tients. Collectively, targeting intracellular movement
pathways of MTFs is valuable for therapeutics, and further
research will help us to find more effective treatments.
Taken together, MTFs and their nuclear translocation are
recently gaining more attention and this is an expanding re-
search area. Further development in this area provides an
effective complement to the mechanisms of signal trans-
duction and gene regulation. Studying nuclear transporta-
tion routes of MTFs provides a new idea for drug design.
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